FXR has shown its protective effect on hepatocytes in many aspects (27): (1) It can reduce the accumulation of BAs in the liver, and can also inhibit the metabolic disorder in the liver, preventing BAs from becoming a potential activator of liver cancer. The gene discussed is NR1H4; the disease is metabolic disease.